Financial Data and Key Metrics Changes - Revenue for Q2 2022 was $37.6 million, up from $36.3 million in Q2 2021, driven by contract execution and growing commercial engagement [19] - The company reported a net loss of $56.8 million, primarily due to a goodwill impairment charge of $35.3 million and increased operating expenses [25] - Adjusted EBITDA was negative $7.7 million for Q2 2022, influenced by delayed contract awards and ongoing investments [25] Business Line Data and Key Metrics Changes - Analytics segment revenue was approximately $19 million, an 18% increase from $16 million in the prior year, attributed to expanded key programs and commercial growth from ProModel [19] - Cyber & Engineering (C&E) business revenue was $18.6 million, down from $20.3 million in the prior year, due to lumpy procurement activity [20] - The gross margin for the analytics segment was 39%, down from 46% in the prior year, while C&E segment gross margin was 24%, up from 22% [23] Market Data and Key Metrics Changes - The firm backlog at the end of Q2 2022 was $325 million, reflecting a 70% increase over the last 18 months, despite a reduction in backlog due to changes in reporting methodology [20][22] - The geopolitical environment has caused delays in contracting processes, impacting revenue timing and projections [8][10] Company Strategy and Development Direction - The company is transitioning from a services-led business to a technology-led model focused on AI-powered analytics, requiring significant investments in people, products, and infrastructure [6] - The acquisition of ProModel is a key part of the growth strategy, enhancing the company's portfolio in high-growth markets such as healthcare and manufacturing [12][13] - The company aims to improve operational efficiency and reduce cash burn through aggressive cost-saving initiatives [26][28] Management's Comments on Operating Environment and Future Outlook - Management acknowledged that the war in Ukraine and a slowing U.S. economy have created challenges, leading to a more conservative revenue forecast for 2022 [7][8] - Despite current challenges, management remains confident in the company's ability to transform and deliver on its vision, with expectations for increased government contract activity in the latter half of the year [29][30] Other Important Information - The company is focusing on integrating AI-powered analytics into various sectors, including healthcare and manufacturing, to enhance operational efficiency [14] - Management emphasized the importance of maintaining strong relationships with federal customers despite delays in contract awards [9] Q&A Session Summary Question: What is the addressable opportunity for additional wins for other healthcare systems in the U.S.? - The company has an established product called FutureFlow Rx, which has significant potential use cases in over 6,000 hospitals in the U.S. [34] Question: What is the long-term margin potential for BigBear as prototype contracts shift to production? - The company expects higher margins from production contracts in 2023, with gross margins anticipated to be in the range of 50% to 60% [37] Question: Are there any projects that have been outright canceled? - No projects have been canceled; however, there has been an elongation of the contracting cycle due to prioritization of funding for Ukraine [54] Question: What is the right run rate for SG&A going forward? - SG&A has increased significantly due to stock compensation and public company expenses, but a lower run rate is expected in Q3 and Q4 [59]
BigBear.ai(BBAI) - 2022 Q2 - Earnings Call Transcript